Lloyd George W. (CIK 1814899) reported 14 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-19). Recent activity: Sell RPRX (79,346 shares), Sell RPRX (30,654 shares), Sell RPRX (110,000 shares), Sell RPRX (47,798 shares), Sell RPRX (4,628 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-19 | Royalty Pharma plc (RPRX) | EVP, Investments & CLO | Sell | 79,346 | $3.1M |
| 2025-12-19 | Royalty Pharma plc (RPRX) | EVP, Investments & CLO | Sell | 30,654 | $1.2M |
| 2025-12-05 | Royalty Pharma plc (RPRX) | EVP, Investments & CLO | Sell | 110,000 | $4.4M |
| 2025-11-21 | Royalty Pharma plc (RPRX) | EVP, Investments & CLO | Sell | 47,798 | $1.8M |
| 2025-11-21 | Royalty Pharma plc (RPRX) | EVP, Investments & CLO | Sell | 4,628 | $180,538 |
| 2025-11-21 | Royalty Pharma plc (RPRX) | EVP, Investments & CLO | Sell | 47,401 | $1.8M |
| 2025-11-21 | Royalty Pharma plc (RPRX) | EVP, Investments & CLO | Sell | 4,599 | $179,407 |
| 2025-11-21 | Royalty Pharma plc (RPRX) | EVP, Investments & CLO | Sell | 25,530 | $977,288 |
| 2025-11-21 | Royalty Pharma plc (RPRX) | EVP, Investments & CLO | Sell | 2,470 | $96,355 |
| 2025-11-21 | Royalty Pharma plc (RPRX) | EVP, Investments & CLO | Sell | 2,770 | $106,063 |
| 2025-11-21 | Royalty Pharma plc (RPRX) | EVP, Investments & CLO | Sell | 230 | $8,977 |
| 2025-11-07 | Royalty Pharma plc (RPRX) | EVP, Investments & CLO | Buy | 6,168 | $0 |
| 2025-08-08 | Royalty Pharma plc (RPRX) | EVP, Investments & CLO | Buy | 3,696 | $0 |
| 2025-05-09 | Royalty Pharma plc (RPRX) | EVP, Investments & CLO | Buy | 48,646 | $0 |
Source: SEC Form 4 filings · as of 2025-12-19